Skip to Main Content

Paper Details

Invariant NKT cell-augmented GM-CSF-secreting tumor vaccine is effective in advanced prostate cancer model.
Cancer Immunol Immunother
1
2022
Author NameAffiliation
Justice ClarkBeth Israel Deaconess Medical Center, Harvard Medical School
Steven P BalkBeth Israel Deaconess Medical Center, Harvard Medical School
  • 1 - 2

Datasets

Release 1.2